nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—SLC18A2—adrenal medulla—germ cell cancer	0.102	0.244	CbGeAlD
Lisdexamfetamine—Logorrhoea—Ifosfamide—germ cell cancer	0.0658	0.116	CcSEcCtD
Lisdexamfetamine—SLC18A2—telencephalic ventricle—germ cell cancer	0.0406	0.0973	CbGeAlD
Lisdexamfetamine—SLC6A3—telencephalic ventricle—germ cell cancer	0.0307	0.0736	CbGeAlD
Lisdexamfetamine—SLC18A2—ganglion—germ cell cancer	0.0253	0.0606	CbGeAlD
Lisdexamfetamine—SLC6A3—ganglion—germ cell cancer	0.0191	0.0458	CbGeAlD
Lisdexamfetamine—SLC6A2—ganglion—germ cell cancer	0.0154	0.037	CbGeAlD
Lisdexamfetamine—Cardiomyopathy—Ifosfamide—germ cell cancer	0.0135	0.0238	CcSEcCtD
Lisdexamfetamine—SLC18A2—brainstem—germ cell cancer	0.011	0.0263	CbGeAlD
Lisdexamfetamine—SLC18A2—telencephalon—germ cell cancer	0.00974	0.0234	CbGeAlD
Lisdexamfetamine—Mania—Ifosfamide—germ cell cancer	0.00949	0.0167	CcSEcCtD
Lisdexamfetamine—Aggression—Bleomycin—germ cell cancer	0.00919	0.0162	CcSEcCtD
Lisdexamfetamine—Amphetamine—SLC22A3—germ cell cancer	0.00847	0.519	CrCbGaD
Lisdexamfetamine—SLC6A3—brainstem—germ cell cancer	0.0083	0.0199	CbGeAlD
Lisdexamfetamine—SLC18A2—uterus—germ cell cancer	0.00808	0.0194	CbGeAlD
Lisdexamfetamine—Methamphetamine—SLC22A3—germ cell cancer	0.00785	0.481	CrCbGaD
Lisdexamfetamine—SLC18A2—medulla oblongata—germ cell cancer	0.00766	0.0184	CbGeAlD
Lisdexamfetamine—SLC6A3—telencephalon—germ cell cancer	0.00737	0.0177	CbGeAlD
Lisdexamfetamine—Dyskinesia—Ifosfamide—germ cell cancer	0.00734	0.013	CcSEcCtD
Lisdexamfetamine—SLC18A2—adrenal gland—germ cell cancer	0.00709	0.017	CbGeAlD
Lisdexamfetamine—Cerebrovascular accident—Vinblastine—germ cell cancer	0.00708	0.0125	CcSEcCtD
Lisdexamfetamine—SLC18A2—midbrain—germ cell cancer	0.007	0.0168	CbGeAlD
Lisdexamfetamine—SLC6A2—brainstem—germ cell cancer	0.0067	0.0161	CbGeAlD
Lisdexamfetamine—Sudden death—Methotrexate—germ cell cancer	0.00638	0.0113	CcSEcCtD
Lisdexamfetamine—SLC18A2—endocrine gland—germ cell cancer	0.00615	0.0147	CbGeAlD
Lisdexamfetamine—ADRA1B—head—germ cell cancer	0.00613	0.0147	CbGeAlD
Lisdexamfetamine—SLC18A2—head—germ cell cancer	0.00607	0.0145	CbGeAlD
Lisdexamfetamine—Cerebrovascular accident—Bleomycin—germ cell cancer	0.00598	0.0106	CcSEcCtD
Lisdexamfetamine—SLC6A2—telencephalon—germ cell cancer	0.00595	0.0143	CbGeAlD
Lisdexamfetamine—SLC18A2—testis—germ cell cancer	0.00586	0.0141	CbGeAlD
Lisdexamfetamine—SLC6A2—decidua—germ cell cancer	0.00564	0.0135	CbGeAlD
Lisdexamfetamine—SLC18A2—cerebellum—germ cell cancer	0.00541	0.013	CbGeAlD
Lisdexamfetamine—Depression—Vinblastine—germ cell cancer	0.00533	0.00941	CcSEcCtD
Lisdexamfetamine—SLC6A3—midbrain—germ cell cancer	0.00529	0.0127	CbGeAlD
Lisdexamfetamine—Acute coronary syndrome—Vinblastine—germ cell cancer	0.00527	0.00931	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Vinblastine—germ cell cancer	0.00524	0.00925	CcSEcCtD
Lisdexamfetamine—SLC6A3—spinal cord—germ cell cancer	0.00516	0.0124	CbGeAlD
Lisdexamfetamine—SLC6A2—gonad—germ cell cancer	0.00496	0.0119	CbGeAlD
Lisdexamfetamine—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00492	0.00869	CcSEcCtD
Lisdexamfetamine—Psychotic disorder—Ifosfamide—germ cell cancer	0.00489	0.00864	CcSEcCtD
Lisdexamfetamine—SLC6A2—medulla oblongata—germ cell cancer	0.00467	0.0112	CbGeAlD
Lisdexamfetamine—SLC6A3—head—germ cell cancer	0.00459	0.011	CbGeAlD
Lisdexamfetamine—Weight decreased—Bleomycin—germ cell cancer	0.00458	0.00809	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00451	0.00796	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Bleomycin—germ cell cancer	0.00445	0.00786	CcSEcCtD
Lisdexamfetamine—ADRA1B—brain—germ cell cancer	0.00444	0.0106	CbGeAlD
Lisdexamfetamine—SLC6A3—testis—germ cell cancer	0.00443	0.0106	CbGeAlD
Lisdexamfetamine—Myocardial infarction—Bleomycin—germ cell cancer	0.00443	0.00782	CcSEcCtD
Lisdexamfetamine—Cerebrovascular accident—Cisplatin—germ cell cancer	0.00441	0.00778	CcSEcCtD
Lisdexamfetamine—SLC18A2—brain—germ cell cancer	0.0044	0.0105	CbGeAlD
Lisdexamfetamine—SLC6A2—adrenal gland—germ cell cancer	0.00432	0.0104	CbGeAlD
Lisdexamfetamine—SLC18A2—lymph node—germ cell cancer	0.00425	0.0102	CbGeAlD
Lisdexamfetamine—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00418	0.00737	CcSEcCtD
Lisdexamfetamine—Irritability—Cisplatin—germ cell cancer	0.00412	0.00728	CcSEcCtD
Lisdexamfetamine—SLC6A3—cerebellum—germ cell cancer	0.00409	0.00982	CbGeAlD
Lisdexamfetamine—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00383	0.00676	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Ifosfamide—germ cell cancer	0.00381	0.00672	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Ifosfamide—germ cell cancer	0.00378	0.00668	CcSEcCtD
Lisdexamfetamine—Hepatitis—Dactinomycin—germ cell cancer	0.00378	0.00668	CcSEcCtD
Lisdexamfetamine—SLC6A2—endocrine gland—germ cell cancer	0.00375	0.00899	CbGeAlD
Lisdexamfetamine—SLC6A2—head—germ cell cancer	0.0037	0.00888	CbGeAlD
Lisdexamfetamine—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.00365	0.00644	CcSEcCtD
Lisdexamfetamine—Convulsion—Vinblastine—germ cell cancer	0.00362	0.00639	CcSEcCtD
Lisdexamfetamine—Hypertension—Vinblastine—germ cell cancer	0.00361	0.00637	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Dactinomycin—germ cell cancer	0.00358	0.00631	CcSEcCtD
Lisdexamfetamine—SLC6A2—testis—germ cell cancer	0.00358	0.00858	CbGeAlD
Lisdexamfetamine—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.00356	0.00629	CcSEcCtD
Lisdexamfetamine—Hepatitis—Ifosfamide—germ cell cancer	0.00347	0.00612	CcSEcCtD
Lisdexamfetamine—Hallucination—Ifosfamide—germ cell cancer	0.00345	0.00609	CcSEcCtD
Lisdexamfetamine—Visual impairment—Ifosfamide—germ cell cancer	0.00334	0.0059	CcSEcCtD
Lisdexamfetamine—SLC6A3—brain—germ cell cancer	0.00333	0.00797	CbGeAlD
Lisdexamfetamine—Acute coronary syndrome—Cisplatin—germ cell cancer	0.00328	0.00579	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Ifosfamide—germ cell cancer	0.00328	0.00578	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Cisplatin—germ cell cancer	0.00326	0.00576	CcSEcCtD
Lisdexamfetamine—Anorexia—Vinblastine—germ cell cancer	0.00325	0.00574	CcSEcCtD
Lisdexamfetamine—Eye disorder—Ifosfamide—germ cell cancer	0.00324	0.00572	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Ifosfamide—germ cell cancer	0.00322	0.00568	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00315	0.00556	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Ifosfamide—germ cell cancer	0.00313	0.00553	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00312	0.00551	CcSEcCtD
Lisdexamfetamine—Mental disorder—Ifosfamide—germ cell cancer	0.00304	0.00536	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.00302	0.00534	CcSEcCtD
Lisdexamfetamine—Malnutrition—Ifosfamide—germ cell cancer	0.00302	0.00533	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Etoposide—germ cell cancer	0.00301	0.00531	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Etoposide—germ cell cancer	0.00299	0.00528	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Vinblastine—germ cell cancer	0.00297	0.00523	CcSEcCtD
Lisdexamfetamine—Constipation—Vinblastine—germ cell cancer	0.00292	0.00515	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Etoposide—germ cell cancer	0.00288	0.00509	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Bleomycin—germ cell cancer	0.00288	0.00509	CcSEcCtD
Lisdexamfetamine—Visual impairment—Cisplatin—germ cell cancer	0.00288	0.00508	CcSEcCtD
Lisdexamfetamine—Vision blurred—Ifosfamide—germ cell cancer	0.00284	0.00502	CcSEcCtD
Lisdexamfetamine—Eye disorder—Cisplatin—germ cell cancer	0.00279	0.00493	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Cisplatin—germ cell cancer	0.00277	0.00489	CcSEcCtD
Lisdexamfetamine—Agitation—Ifosfamide—germ cell cancer	0.00277	0.00489	CcSEcCtD
Lisdexamfetamine—Angioedema—Ifosfamide—germ cell cancer	0.00276	0.00487	CcSEcCtD
Lisdexamfetamine—Anorexia—Bleomycin—germ cell cancer	0.00275	0.00485	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Cisplatin—germ cell cancer	0.0027	0.00476	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00269	0.00475	CcSEcCtD
Lisdexamfetamine—SLC6A2—brain—germ cell cancer	0.00268	0.00643	CbGeAlD
Lisdexamfetamine—Palpitations—Ifosfamide—germ cell cancer	0.00267	0.00471	CcSEcCtD
Lisdexamfetamine—Convulsion—Ifosfamide—germ cell cancer	0.00261	0.00461	CcSEcCtD
Lisdexamfetamine—Hypertension—Ifosfamide—germ cell cancer	0.00261	0.0046	CcSEcCtD
Lisdexamfetamine—Malnutrition—Cisplatin—germ cell cancer	0.0026	0.00459	CcSEcCtD
Lisdexamfetamine—SLC6A2—lymph node—germ cell cancer	0.00259	0.00622	CbGeAlD
Lisdexamfetamine—Erythema multiforme—Etoposide—germ cell cancer	0.00259	0.00457	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Bleomycin—germ cell cancer	0.00257	0.00453	CcSEcCtD
Lisdexamfetamine—Anorexia—Dactinomycin—germ cell cancer	0.00256	0.00452	CcSEcCtD
Lisdexamfetamine—Eye disorder—Etoposide—germ cell cancer	0.00256	0.00452	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00255	0.0045	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Etoposide—germ cell cancer	0.00254	0.00448	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Vinblastine—germ cell cancer	0.00251	0.00444	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Bleomycin—germ cell cancer	0.0025	0.00442	CcSEcCtD
Lisdexamfetamine—Visual disturbance—Methotrexate—germ cell cancer	0.0025	0.00441	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Etoposide—germ cell cancer	0.00247	0.00436	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Etoposide—germ cell cancer	0.00247	0.00435	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00246	0.00435	CcSEcCtD
Lisdexamfetamine—Vision blurred—Cisplatin—germ cell cancer	0.00245	0.00433	CcSEcCtD
Lisdexamfetamine—Asthenia—Vinblastine—germ cell cancer	0.00245	0.00432	CcSEcCtD
Lisdexamfetamine—Tremor—Cisplatin—germ cell cancer	0.00244	0.0043	CcSEcCtD
Lisdexamfetamine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.00242	0.00427	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Ifosfamide—germ cell cancer	0.00242	0.00426	CcSEcCtD
Lisdexamfetamine—Skin disorder—Ifosfamide—germ cell cancer	0.00239	0.00422	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00238	0.0042	CcSEcCtD
Lisdexamfetamine—Anorexia—Ifosfamide—germ cell cancer	0.00235	0.00414	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Dactinomycin—germ cell cancer	0.00234	0.00412	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Vinblastine—germ cell cancer	0.00233	0.00412	CcSEcCtD
Lisdexamfetamine—Fatigue—Dactinomycin—germ cell cancer	0.00232	0.00409	CcSEcCtD
Lisdexamfetamine—Urticaria—Bleomycin—germ cell cancer	0.00229	0.00404	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Bleomycin—germ cell cancer	0.00228	0.00402	CcSEcCtD
Lisdexamfetamine—Irritability—Methotrexate—germ cell cancer	0.00226	0.00399	CcSEcCtD
Lisdexamfetamine—Dizziness—Vinblastine—germ cell cancer	0.00226	0.00398	CcSEcCtD
Lisdexamfetamine—Convulsion—Cisplatin—germ cell cancer	0.00225	0.00398	CcSEcCtD
Lisdexamfetamine—Anxiety—Cisplatin—germ cell cancer	0.00221	0.00389	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.0022	0.00388	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Ifosfamide—germ cell cancer	0.0022	0.00387	CcSEcCtD
Lisdexamfetamine—Somnolence—Ifosfamide—germ cell cancer	0.00219	0.00386	CcSEcCtD
Lisdexamfetamine—Vomiting—Vinblastine—germ cell cancer	0.00217	0.00383	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Ifosfamide—germ cell cancer	0.00214	0.00378	CcSEcCtD
Lisdexamfetamine—Headache—Vinblastine—germ cell cancer	0.00214	0.00377	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.00213	0.00377	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00213	0.00375	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Dactinomycin—germ cell cancer	0.00212	0.00375	CcSEcCtD
Lisdexamfetamine—Fatigue—Ifosfamide—germ cell cancer	0.00212	0.00375	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Cisplatin—germ cell cancer	0.00212	0.00375	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Bleomycin—germ cell cancer	0.00212	0.00375	CcSEcCtD
Lisdexamfetamine—Constipation—Ifosfamide—germ cell cancer	0.00211	0.00372	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Cisplatin—germ cell cancer	0.00208	0.00367	CcSEcCtD
Lisdexamfetamine—Tachycardia—Cisplatin—germ cell cancer	0.00207	0.00366	CcSEcCtD
Lisdexamfetamine—Asthenia—Bleomycin—germ cell cancer	0.00207	0.00365	CcSEcCtD
Lisdexamfetamine—Convulsion—Etoposide—germ cell cancer	0.00206	0.00364	CcSEcCtD
Lisdexamfetamine—Skin disorder—Cisplatin—germ cell cancer	0.00206	0.00364	CcSEcCtD
Lisdexamfetamine—Hypertension—Etoposide—germ cell cancer	0.00206	0.00363	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Cisplatin—germ cell cancer	0.00205	0.00362	CcSEcCtD
Lisdexamfetamine—Nausea—Vinblastine—germ cell cancer	0.00203	0.00358	CcSEcCtD
Lisdexamfetamine—Anorexia—Cisplatin—germ cell cancer	0.00202	0.00357	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00201	0.00356	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Dactinomycin—germ cell cancer	0.00198	0.00349	CcSEcCtD
Lisdexamfetamine—Urticaria—Ifosfamide—germ cell cancer	0.00196	0.00345	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Ifosfamide—germ cell cancer	0.00195	0.00344	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Etoposide—germ cell cancer	0.00195	0.00343	CcSEcCtD
Lisdexamfetamine—Asthenia—Dactinomycin—germ cell cancer	0.00193	0.0034	CcSEcCtD
Lisdexamfetamine—Tachycardia—Etoposide—germ cell cancer	0.0019	0.00335	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Cisplatin—germ cell cancer	0.00189	0.00334	CcSEcCtD
Lisdexamfetamine—Skin disorder—Etoposide—germ cell cancer	0.00189	0.00333	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Methotrexate—germ cell cancer	0.00189	0.00333	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Etoposide—germ cell cancer	0.00188	0.00332	CcSEcCtD
Lisdexamfetamine—Anorexia—Etoposide—germ cell cancer	0.00185	0.00327	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Cisplatin—germ cell cancer	0.00185	0.00326	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Dactinomycin—germ cell cancer	0.00184	0.00324	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00183	0.00323	CcSEcCtD
Lisdexamfetamine—Vomiting—Bleomycin—germ cell cancer	0.00183	0.00323	CcSEcCtD
Lisdexamfetamine—Depression—Methotrexate—germ cell cancer	0.00182	0.00321	CcSEcCtD
Lisdexamfetamine—Rash—Bleomycin—germ cell cancer	0.00182	0.00321	CcSEcCtD
Lisdexamfetamine—Dermatitis—Bleomycin—germ cell cancer	0.00182	0.0032	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Ifosfamide—germ cell cancer	0.00181	0.0032	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.00181	0.0032	CcSEcCtD
Lisdexamfetamine—Asthenia—Ifosfamide—germ cell cancer	0.00177	0.00312	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Etoposide—germ cell cancer	0.00173	0.00306	CcSEcCtD
Lisdexamfetamine—Somnolence—Etoposide—germ cell cancer	0.00173	0.00305	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00173	0.00305	CcSEcCtD
Lisdexamfetamine—Nausea—Bleomycin—germ cell cancer	0.00171	0.00302	CcSEcCtD
Lisdexamfetamine—Vomiting—Dactinomycin—germ cell cancer	0.00171	0.00302	CcSEcCtD
Lisdexamfetamine—Rash—Dactinomycin—germ cell cancer	0.00169	0.00299	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Etoposide—germ cell cancer	0.00169	0.00298	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Ifosfamide—germ cell cancer	0.00168	0.00297	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00168	0.00296	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Cisplatin—germ cell cancer	0.00168	0.00296	CcSEcCtD
Lisdexamfetamine—Fatigue—Etoposide—germ cell cancer	0.00168	0.00296	CcSEcCtD
Lisdexamfetamine—Constipation—Etoposide—germ cell cancer	0.00166	0.00294	CcSEcCtD
Lisdexamfetamine—Hepatitis—Methotrexate—germ cell cancer	0.00164	0.00289	CcSEcCtD
Lisdexamfetamine—Dizziness—Ifosfamide—germ cell cancer	0.00163	0.00287	CcSEcCtD
Lisdexamfetamine—Nausea—Dactinomycin—germ cell cancer	0.0016	0.00282	CcSEcCtD
Lisdexamfetamine—Visual impairment—Methotrexate—germ cell cancer	0.00158	0.00279	CcSEcCtD
Lisdexamfetamine—Vomiting—Ifosfamide—germ cell cancer	0.00157	0.00276	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Cisplatin—germ cell cancer	0.00156	0.00276	CcSEcCtD
Lisdexamfetamine—Rash—Ifosfamide—germ cell cancer	0.00155	0.00274	CcSEcCtD
Lisdexamfetamine—Dermatitis—Ifosfamide—germ cell cancer	0.00155	0.00274	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Methotrexate—germ cell cancer	0.00155	0.00274	CcSEcCtD
Lisdexamfetamine—Urticaria—Etoposide—germ cell cancer	0.00155	0.00273	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Etoposide—germ cell cancer	0.00154	0.00271	CcSEcCtD
Lisdexamfetamine—Eye disorder—Methotrexate—germ cell cancer	0.00153	0.0027	CcSEcCtD
Lisdexamfetamine—Asthenia—Cisplatin—germ cell cancer	0.00152	0.00269	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Methotrexate—germ cell cancer	0.00152	0.00269	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Methotrexate—germ cell cancer	0.00148	0.00261	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Methotrexate—germ cell cancer	0.00148	0.00261	CcSEcCtD
Lisdexamfetamine—Nausea—Ifosfamide—germ cell cancer	0.00146	0.00258	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Cisplatin—germ cell cancer	0.00145	0.00256	CcSEcCtD
Lisdexamfetamine—Mental disorder—Methotrexate—germ cell cancer	0.00144	0.00254	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Etoposide—germ cell cancer	0.00143	0.00253	CcSEcCtD
Lisdexamfetamine—Malnutrition—Methotrexate—germ cell cancer	0.00143	0.00252	CcSEcCtD
Lisdexamfetamine—Asthenia—Etoposide—germ cell cancer	0.0014	0.00246	CcSEcCtD
Lisdexamfetamine—Vomiting—Cisplatin—germ cell cancer	0.00135	0.00238	CcSEcCtD
Lisdexamfetamine—Vision blurred—Methotrexate—germ cell cancer	0.00135	0.00237	CcSEcCtD
Lisdexamfetamine—Rash—Cisplatin—germ cell cancer	0.00134	0.00236	CcSEcCtD
Lisdexamfetamine—Dermatitis—Cisplatin—germ cell cancer	0.00134	0.00236	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Etoposide—germ cell cancer	0.00133	0.00235	CcSEcCtD
Lisdexamfetamine—Dizziness—Etoposide—germ cell cancer	0.00129	0.00227	CcSEcCtD
Lisdexamfetamine—Nausea—Cisplatin—germ cell cancer	0.00126	0.00223	CcSEcCtD
Lisdexamfetamine—Convulsion—Methotrexate—germ cell cancer	0.00124	0.00218	CcSEcCtD
Lisdexamfetamine—Vomiting—Etoposide—germ cell cancer	0.00124	0.00218	CcSEcCtD
Lisdexamfetamine—Rash—Etoposide—germ cell cancer	0.00123	0.00216	CcSEcCtD
Lisdexamfetamine—Dermatitis—Etoposide—germ cell cancer	0.00123	0.00216	CcSEcCtD
Lisdexamfetamine—Headache—Etoposide—germ cell cancer	0.00122	0.00215	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00121	0.00213	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Methotrexate—germ cell cancer	0.00117	0.00206	CcSEcCtD
Lisdexamfetamine—Nausea—Etoposide—germ cell cancer	0.00116	0.00204	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Methotrexate—germ cell cancer	0.00114	0.00202	CcSEcCtD
Lisdexamfetamine—Skin disorder—Methotrexate—germ cell cancer	0.00113	0.002	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Methotrexate—germ cell cancer	0.00113	0.00199	CcSEcCtD
Lisdexamfetamine—Anorexia—Methotrexate—germ cell cancer	0.00111	0.00196	CcSEcCtD
Lisdexamfetamine—Insomnia—Methotrexate—germ cell cancer	0.00105	0.00186	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Methotrexate—germ cell cancer	0.00104	0.00183	CcSEcCtD
Lisdexamfetamine—Somnolence—Methotrexate—germ cell cancer	0.00104	0.00183	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Methotrexate—germ cell cancer	0.00103	0.00181	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Methotrexate—germ cell cancer	0.00101	0.00179	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00101	0.00178	CcSEcCtD
Lisdexamfetamine—Fatigue—Methotrexate—germ cell cancer	0.001	0.00177	CcSEcCtD
Lisdexamfetamine—Urticaria—Methotrexate—germ cell cancer	0.000926	0.00163	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Methotrexate—germ cell cancer	0.000921	0.00163	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Methotrexate—germ cell cancer	0.000858	0.00151	CcSEcCtD
Lisdexamfetamine—Asthenia—Methotrexate—germ cell cancer	0.000836	0.00148	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Methotrexate—germ cell cancer	0.000797	0.00141	CcSEcCtD
Lisdexamfetamine—Dizziness—Methotrexate—germ cell cancer	0.00077	0.00136	CcSEcCtD
Lisdexamfetamine—Vomiting—Methotrexate—germ cell cancer	0.000741	0.00131	CcSEcCtD
Lisdexamfetamine—Rash—Methotrexate—germ cell cancer	0.000735	0.0013	CcSEcCtD
Lisdexamfetamine—Dermatitis—Methotrexate—germ cell cancer	0.000734	0.0013	CcSEcCtD
Lisdexamfetamine—Headache—Methotrexate—germ cell cancer	0.00073	0.00129	CcSEcCtD
Lisdexamfetamine—Nausea—Methotrexate—germ cell cancer	0.000692	0.00122	CcSEcCtD
